ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ROBERT VONRUEDEN MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,901Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 663

$527K Total Retail Price of All Prescriptions

Rank: 58 out of 663

791 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 791 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 791 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 950 891 1 1
LISINOPRIL 816 788 2 2
OMEPRAZOLE 643 586 3 4
AMLODIPINE BESYLATE 427 421 4 5
LEVOTHROID 370 362 5 19
ATENOLOL 356 345 6 10
METFORMIN HCL 350 317 7 9
METOPROLOL TARTRATE 303 292 8 11
WARFARIN SODIUM 302 285 9 8
FUROSEMIDE 270 269 10 7
LEVOTHYROXINE SODIUM 257 245 11 3
LOSARTAN POTASSIUM 257 249 11 14
TRAMADOL HCL 252 250 13 17
NORTRIPTYLINE HCL 250 245 14 63
HYDROCODONE-ACETAMINOPHEN 244 210 S3 15 6
TAMSULOSIN HCL 216 210 16 24
ALENDRONATE SODIUM 203 185 17 15
TERAZOSIN HCL 194 191 18 38
GLIPIZIDE 190 179 19 29
ATORVASTATIN CALCIUM 178 164 20 13
ZOLPIDEM TARTRATE 171 151 21 16
ALLOPURINOL 171 168 21 28
TRAZODONE HCL 165 155 23 34
HYDROCHLOROTHIAZIDE 165 158 23 12
FLUTICASONE PROPIONATE 164 138 25 27
PREDNISONE 145 129 26 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 139 27 22
GABAPENTIN 142 128 28 20
FLUOXETINE HCL 140 140 29 32
NOVOLIN N 133 119 30 44
PROAIR HFA 121 116 31 33
MORPHINE SULFATE ER 115 75 S2 32 51
LOVASTATIN 105 97 33 30
OXYCODONE-ACETAMINOPHEN 101 87 S2 34 26
DOXYCYCLINE HYCLATE 96 79 35 118
METOPROLOL SUCCINATE 96 96 35 25
DULERA 94 91 37 218
K-TAB 93 83 38 36
PRAVASTATIN SODIUM 90 90 39 21
DIGOXIN 89 89 40 50
CITALOPRAM HBR 88 77 41 18
VENLAFAXINE HCL ER 87 82 42 86
CIPROFLOXACIN HCL 81 76 43 74
FINASTERIDE 78 78 44 56
INSULIN SYRINGE 75 69 45 55
RANITIDINE HCL 74 63 46 31
HYDRALAZINE HCL 73 73 47 101
TRIAMTERENE-HYDROCHLOROTHIAZID 68 68 48 49
TRIAMTERENE-HCTZ 67 57 49 42
GALANTAMINE HBR 66 66 50 253
SERTRALINE HCL 66 66 50 35
LACTULOSE 57 56 52 111
QVAR 56 51 53 91
PROPRANOLOL HCL 54 42 54 120
CRESTOR 52 49 55 37
ZOSTAVAX 51 50 56 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.